Clinical Trials on Gram-positive, Skin Infections
Total 9950 results
-
University Children's Hospital BaselTerminatedStreptococcal InfectionsSwitzerland
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences Institute; North Carolina...CompletedClostridium DifficileUnited States
-
London School of Hygiene and Tropical MedicineMurdoch Childrens Research Institute; Kirby Institute; Atoifi Adventist Hospital...CompletedYaws | Scabies | ImpetigoSolomon Islands
-
Theravance BiopharmaCompletedSerious Infections Due to Known or Suspected Gram-positive PathogensUnited States
-
Taipei Medical University WanFang HospitalUnknownSerious Gram-positive InfectionsTaiwan
-
Clinical Directors NetworkPatient-Centered Outcomes Research Institute; Rockefeller UniversityUnknownRecurrence | Staphylococcal Skin Infections | Antibiotic Resistance | Methicillin-Resistant Staphylococcus AureusUnited States
-
Michael E. DeBakey VA Medical CenterBaylor College of Medicine; CepheidCompletedBacteremia | Staphylococcus Aureus | Staphylococcal Skin InfectionsUnited States
-
MJM BontenUniversiteit Antwerpen; Universitätsklinikum Köln; Da VolterraCompletedClostridium DifficileGermany, Spain, France, Greece, Netherlands, Romania
-
Astellas Pharma Europe Ltd.Cubist Pharmaceuticals LLCTerminatedClostridium DifficileSpain, France, Germany, Greece, Denmark, Austria, Poland
-
Chinese University of Hong KongUnknownClostridium Difficile Infection | Clostridium DifficileHong Kong
-
Medical University of SilesiaUnknownClostridium Difficile
-
Hvidovre University HospitalUnknown
-
St. Petersburg Research Institute of Vaccines and...CompletedTolerability and Reactogenicity Trial of the Recombinant Tuberculosis Allergen in Healthy VolunteersTuberculosis | Skin TestsRussian Federation
-
NovartisTerminatedStaphylococcal Skin InfectionsItaly
-
Minervax ApSSimbec-Orion GroupEnrolling by invitationGroup B Streptococcus InfectionUnited Kingdom
-
Jiangsu Province Centers for Disease Control and...Third Military Medical University; Chengdu Olymvax Biopharmaceuticals Inc.CompletedStaphylococcus Aureus InfectionChina
-
St George's, University of LondonUniversity of Nottingham; Medical Research Council; Public Health EnglandRecruitingStreptococcus Agalactiae InfectionUnited Kingdom
-
PfizerCompletedClostridium Difficile InfectionUnited States, Spain, Belgium, Taiwan, Japan, Portugal, Colombia, Korea, Republic of, Poland, Australia, Germany, Canada, Argentina, Bulgaria, Chile, Czechia, Finland, France, Hungary, Peru, Slovakia, Sweden, United Kingdom
-
Medical College of WisconsinCompletedClostridium Difficile InfectionUnited States
-
Meridian Bioscience, Inc.CompletedStreptococcus Agalactiae InfectionCanada, United States
-
National Cancer Institute (NCI)Completed
-
Valneva Austria GmbHCompletedClostridium Difficile InfectionAustria, Hungary
-
Merck Sharp & Dohme LLCCompletedHerpes Zoster | Pneumococcal Infection
-
Jiangsu Province Centers for Disease Control and...Chengdu Olymvax Biopharmaceuticals Inc.; PLA Army Medical UniversityCompletedStaphylococcus Aureus InfectionChina
-
Jiangsu Province Centers for Disease Control and...Third Military Medical University; Chengdu Olymvax Biopharmaceuticals Inc.CompletedStaphylococcus Aureus InfectionChina
-
National Institute of Allergy and Infectious Diseases...Completed
-
Hospital Universitario Evangelico de CuritibaNot yet recruitingClostridium Difficile Infections
-
Shanghai Pulmonary Hospital, Shanghai, ChinaRecruitingMycobacterium Pulmonary InfectionChina
-
Leiden University Medical CenterRecruiting
-
Emory UniversitySuspendedClostridium Difficile InfectionUnited States
-
VA Office of Research and DevelopmentTerminatedMicrobiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH) (MATCH)Clostridium Difficile InfectionUnited States
-
Meridian Bioscience, Inc.CompletedClostridium Difficile InfectionUnited States, Canada
-
MGB Biopharma LimitedSyneos HealthCompletedClostridium Difficile InfectionCanada, United States
-
Sanofi Pasteur, a Sanofi CompanyCompletedClostridium Difficile InfectionJapan
-
National Institute of Allergy and Infectious Diseases...CompletedClostridium Difficile InfectionUnited States
-
NovaDigm Therapeutics, Inc.United States Department of Defense; Cetero Research, San AntonioCompletedCandidiasis | Staphylococcal InfectionsUnited States
-
Johns Hopkins Bloomberg School of Public HealthNational Institute of General Medical Sciences (NIGMS)RecruitingStaphylococcus Aureus InfectionUnited States
-
Groupe Hospitalier Paris Saint JosephRecruitingClostridium Difficile InfectionFrance
-
Jonathan GisserRecruitingClostridium DifficileUnited States
-
Methodist Health SystemCompleted
-
University of NebraskaTerminatedStaphylococcus AureusUnited States
-
Mabwell (Shanghai) Bioscience Co., Ltd.Huashan HospitalCompletedStaphylococcus Aureus InfectionChina
-
University of Wisconsin, MadisonWithdrawnClostridium Difficile Infection
-
Yves LongtinSir Mortimer B. Davis - Jewish General Hospital; Becton, Dickinson and CompanyCompletedClostridium DifficileCanada
-
Destiny Pharma PlcCompletedStaphylococcus Aureus InfectionUnited Kingdom
-
Merck Sharp & Dohme LLCCompletedPneumococcal InfectionUnited States, Puerto Rico
-
Merck Sharp & Dohme LLCCompletedPneumococcal InfectionUnited States, Australia, Canada, Chile, Japan, Korea, Republic of, New Zealand, Poland
-
Merck Sharp & Dohme LLCCompleted
-
Assistance Publique - Hôpitaux de ParisCompleted